Accuray Incorporated (ARAY) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Accuray Incorporated (ARAY:NASDAQ), powered by AI.

Current Price
$0.42
P/E Ratio
-27.1
Market Cap
43M
Sector
Healthcare
What is the Accuray Incorporated stock price forecast?

Accuray Incorporated is currently trading at $0.42. View real-time AI analysis on Alpha Lenz.

What is Accuray Incorporated insider trading activity?

View the latest insider trading data for Accuray Incorporated on Alpha Lenz.

What is Accuray Incorporated's P/E ratio?

Accuray Incorporated's P/E ratio is -27.1.

Accuray Incorporated

$0.42
NASDAQARAY
Ask about Accuray Incorporated's future dividend policy...
Alpha Chat Insight

Accuray Incorporated trades at a P/E of -27.1 (undervalued) with modest ROE of -2.5%.

Ask for details

Company Overview

Accuray Incorporated is a medical device company specializing in the development and sale of precise tumor treatments. Primarily known for its innovative radiation therapy systems, the company developed technologies such as the CyberKnife System, used for robotic radiosurgery, and the TomoTherapy System, designed for helical radiation therapy. These devices are pivotal in treating a wide range of cancers and are renowned for enhancing precision and accuracy, thereby minimizing damage to surrounding healthy tissues. Accuray's products are extensively used in healthcare facilities worldwide, playing a crucial role in advancing cancer treatment options. By focusing on combining state-of-the-art technology with patient-centered care, Accuray aims to improve therapeutic outcomes and quality of life for cancer patients. Occupying a significant position in the oncology sector, Accuray Incorporated continues to contribute to the evolution of radiation therapy techniques, making cancer care more effective and accessible.

CEOMs. Suzanne Winter M.B.A.
SectorHealthcare
IndustryMedical Devices
Employees990

Company Statistics

(FY 2025)

Profile

Market Cap$43.16M
Revenue$458.50M
Shares Out0.00
Employees990

Margins

Gross32.05%
EBITDA4.38%
Operating1.71%
Pre-Tax0.25%
Net-0.35%

Valuation

P/E-27.13
P/B0.53
EV/Sales0.09
EV/EBITDA8.08
P/FCF-7.62

Growth (CAGR)

Rev 3Yr2.17%
Rev 5Yr3.67%
Op Inc 3Yr-1.28%
Op Inc 5Yr-8.97%
Net Inc 3YrN/A
Net Inc 5YrN/A

Returns

ROA-0.34%
ROE-2.52%
ROIC3.00%

Financial Health

Cash & Cash Equivalents$57.42M
Net Debt$331.65M
Debt/Equity479.33%
Interest CovN/A
Ask Alpha Chat

Frequently Asked Questions

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Accuray Incorporated (Healthcare) Stock Forecast & Analysis $0.42 | Alpha Lenz